TSF-a New Angiogenesis Inhibitory Factor and Its Design and Expression

沈先荣,吉冬梅,贾福星,胡幼卿,蒋定文,邓新贤,储智勇,王玲,雷呈祥,黄建生,胡忻然,任大明
DOI: https://doi.org/10.3760/cma.j.issn.1009-6906.2002.04.022
2002-01-01
Abstract:Objective To detect the inhibitory effect of TSF protein, which was designed from PF4(58~70) and TSP1(429~459) and expressed in E.coli ,on endothelial cells. Methods PF4(58~70) and TSP1(429~459) were ligated with GLy Pro Gly bridge to generat TSF gene. The TSF gene was ligated and cloned into pUC118 plasmid to sequence. Then ,TSF gene from the correct sequence of pUC118/TSF was cloned into a pGEX 2T expression vector to generat recombined plasmid-pGEX 2T/TSF, and transformed into attenuated E.coli JM 109 to construct recombined M109(pGEX 2T/TSF) strain. With the method of MTT assay, the effects of TSF on the proliferation of endothelial cell were detected. Results TSF was expressed highly in inclusion, and the quantity of TSF was 28% in the total of E.coli proteins. The purification procedure was established, and the purified TSF and its fused protein GST TSF were obtained. TSF significantly suppressed capillary EC proliferation in a dose dependent manner. The fuse protein GST TSF, the peptide PF4(58~70) and TSP1(429~459) also inhibited EC proliferation, respectively, but their inhibition rates were not as high as TSF. Conclusions The design of the TSF gene was successful. TSF has significant inhibitory effect on angiogenesis in vitro. TSF with its anti angiogenic activity, should be a useful source of angiogenesis inhibitor.
What problem does this paper attempt to address?